首站-论文投稿智能助手
典型文献
Fas -670 A/G polymorphism predicts prognosis of hepatocellular carcinoma after curative resection in Chinese Han population
文献摘要:
Background: Apoptosis, also called programmed cell death, is a genetically controlled process against hyperproliferation and malignancy. The Fas-Fas ligand (FasL) system is considered a major pathway for apoptosis in cells and tissues. Thus, this study aimed to investigate whether single nucleotide polymor- phisms (SNPs) in Fas and FasL gene may have effects on the recurrence and survival of patients with hepatocellular carcinoma (HCC) after curative hepatectomy.Methods: We investigated the relationship between Fas rs1800682, rs2234767 and FasL rs763110 poly- morphisms and recurrence-free survival (RFS) as well as overall survival (OS) in 117 Chinese Han patients with HCC who underwent hepatectomy. Results: In Kaplan-Meier survival analysis, only Fas rs1800682 (-670 A/G) was associated with RFS and OS. Compared with AA genotype, the AG/GG genotype was significantly associated with better RFS ( P = 0.008) and OS ( P = 0.020). Moreover, multivariate Cox regression analysis showed that Fas rs1800682 remained as a significant independent predictor of RFS for HCC patients with hepatectomy [AG/GG vs. AA: adjusted hazard ratio = 0.464, 95% confidence interval: 0.275–0.782, P = 0.004], but was not an independent predictor of OS ( P = 0.395). Conclusions: This study demonstrated that Fas -670 G allele may play a protective role in the recurrence and survival of HCC patients with hepatectomy. Furthermore, Fas rs1800682 polymorphism might be a promising biomarker for HCC patients after hepatectomy.
文献关键词:
作者姓名:
Xin-Yi Guo;Yi-Lin Xia;Zhi-Yang Li;Ran Li;Yang Fan;Wen-Mo Yao;Fei Liu
作者机构:
West China School of Medicine,West China Hospital,Sichuan University,Chengdu 610041,China;Department of Liver Surgery&Liver Transplantation Center,West China Hospital,Sichuan University,Chengdu 610041,China
引用格式:
[1]Xin-Yi Guo;Yi-Lin Xia;Zhi-Yang Li;Ran Li;Yang Fan;Wen-Mo Yao;Fei Liu-.Fas -670 A/G polymorphism predicts prognosis of hepatocellular carcinoma after curative resection in Chinese Han population)[J].国际肝胆胰疾病杂志(英文版),2022(01):33-40
A类:
phisms,rs1800682,rs2234767,rs763110
B类:
polymorphism,predicts,prognosis,hepatocellular,carcinoma,after,curative,resection,Chinese,Han,population,Background,Apoptosis,also,called,programmed,death,genetically,controlled,process,against,hyperproliferation,malignancy,ligand,FasL,system,considered,major,pathway,apoptosis,cells,tissues,Thus,this,study,aimed,whether,single,nucleotide,SNPs,may,have,effects,recurrence,survival,patients,HCC,hepatectomy,Methods,We,investigated,relationship,between,morphisms,free,RFS,well,overall,OS,who,underwent,Results,In,Kaplan,Meier,analysis,only,was,associated,Compared,AA,genotype,AG,GG,significantly,better,Moreover,multivariate,Cox,regression,showed,that,remained,independent,predictor,adjusted,hazard,confidence,interval,but,Conclusions,This,demonstrated,allele,play,protective,role,Furthermore,might,promising,biomarker
AB值:
0.490726
相似文献
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Jia Lu;Ting Li;Zhichao Liao;Hui Yu;Yongtian Zhao;Haixiao Wu;Zhiwu Ren;Jun Zhao;Ruwei Xing;Sheng Teng;Yun Yang;Xiangchun Li;Kexin Chen;Jonathan Trent;Jilong Yang-Department of Bone and Soft Tissue Tumor,2Department of Infection Management,3Key Laboratory of Molecular Cancer Epidemiology,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;YuceBio Technology Co.,Ltd.,Shenzhen 518172,China;Department of Epidemiology and Biostatistics,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;Sarcoma Multidisciplinary Program,Sylvester Comprehensive Cancer Center,The University of Miami,Miami,FL 33136,USA
Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
Sung Uk Lee;Jinsil Seong;Tae Hyun Kim;Jung Ho Im;Woo Chul Kim;Kyubo Kim;Hae Jin Park;Tae Gyu Kim;Youngkyong Kim;Bae Kwon Jeong;Jin Hee Kim;Byoung Hyuck Kim;Taek-Keun Nam-Center for Proton Therapy and Center for Liver and Pancreatobiliary Cancer,National Cancer Center,Goyang 10408,Korea;Department of Radiation Oncology,Yonsei Cancer Center,Yonsei University College of Medicine,Seoul 03722,Korea;Department of Radiation Oncology,CHA Bundang Medical Center,CHA University School of Medicine,Seongnam 13497,Korea;Department of Radiation Oncology,Inha University Hospital,Inha University School of Medicine,Incheon 22332,Korea;Department of Radiation Oncology,Ewha Womans University Mokdong Hospital,Ewha Womans University College of Medicine,Seoul 07985,Korea;Department of Radiation Oncology,Hanyang University Medical Center,Hanyang University College of Medicine,Seoul 04763,Korea;Department of Radiation Oncology,Samsung Changwon Hospital,Sungkyunkwan University School of Medicine,Changwon 51353,Korea;Department of Radiation Oncology,Kyung Hee University Hospital,Kyung Hee University College of Medicine,Seoul 02447,Korea;Department of Radiation Oncology,Gyeongsang National University Hospital,Gyeongsang National University College of Medicine,Jinju 52727,Korea;0Department of Radiation Oncology,Dongsan Medical Center,Keimyung University School of Medicine,Daegu 41931,Korea;1Department of Radiation Oncology,Seoul Metropolitan Government Seoul National University Boramae Medical Center,Seoul 07061,Korea;2Department of Radiation Oncology,Chonnam National University Hwasun Hospital,Chonnam National University College of Medicine,Hwasun 58128,Korea
Identification of hub genes and their novel diagnostic and prognostic significance in pancreatic adenocarcinoma
Duo Zuo;Yongzi Chen;Xinwei Zhang;Zhuozhi Wang;Wenna Jiang;Fan Tang;Runfen Cheng;Yi Sun;Lu Sun;Li Ren;Rui Liu-Department of Clinical Laboratory;Department of Tumor Cell Biology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;School of Biomedical Engineering,Tianjin Medical University,Tianjin 300070,China;Department of Pathology,Tianjin Huanhu Hospital,Tianjin 300350,China;Department of Pathology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;School of Pharmacy,Tianjin Medical University,Tianjin 300070,China;Department of Gastrointestinal Medical Oncology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China
Tenofovir vs. entecavir on recurrence of hepatitis B virus-related hepatocellular carcinoma beyond Milan criteria after hepatectomy
Shen Junyi;Qi Weili;Dai Junlong;Leng Shusheng;Jiang Kangyi;Zhang Yu;Ran Shun;Li Chuan;Wen Tianfu-Department of Liver Surgery and Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China;Laboratory of Liver Transplantation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China;Institute of Clinical Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China;Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Chengdu University, Chengdu, Sichuan 610072, China;Department of Hepatobiliary and Pancreatic Surgery, The People's Hospital of Leshan, Leshan, Sichuan 614700, China;Department of Hepatobiliary Surgery, Sichuan Provincial People's Hospital, Chinese Academy of Sciences, Chengdu, Sichuan 610072, China;Department of Hepatobiliary Surgery, Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, Guizhou 550000, China
A novel chemotherapy strategy for advanced hepatocellular carcinoma: a multicenter retrospective study
Sun Juxian;Liu Chang;Shi Jie;Wang Nanya;Jiang Dafeng;Mao Feifei;Gu Jingwen;Zhou Liping;Shen Li;Yee Lau Wan;Cheng Shuqun-Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai 200433, China;Department of Integrative Oncology, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai 200433, China;Department of Outpatient Department, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai 200433, China;Department of Oncology, First Hospital of Jilin University, Changchun, Jilin 130000, China;Department of Oncology Zhejiang Sian International Hospital, Jiaxing, Zhejiang 314000, China;Tongji University Cancer Center, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai 200040, China;Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR 999077, China
Coupling radiomics analysis of CT image with diversification of tumor ecosystem:A new insight to overall survival in stage Ⅰ-Ⅲ colorectal cancer
Yanqi Huang;Lan He;Zhenhui Li;Xin Chen;Chu Han;Ke Zhao;Yuan Zhang;Jinrong Qu;Yun Mao;Changhong Liang;Zaiyi Liu-The Second School of Clinical Medicine,Southern Medical University,Guangzhou 510515,China;Department of Radiology,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou 510080,China;Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou 510080,China;Department of Radiology,the Third Affiliated Hospital of Kunming Medical University,Yunnan Cancer Hospital,Yunnan Cancer Center,Kunming 650118,China;Department of Radiology,Guangzhou First People's Hospital,School of Medicine,South China University of Technology,Guangzhou 510180,China;Department of Radiology,the Affiliated Cancer Hospital of Zhengzhou University&Henan Cancer Hospital,Zhengzhou 450003,China;Department of Radiology,the First Affiliated Hospital of Chongqing Medical University,Chongqing 400042,China
Predictors of pathologic complete response in patients with residual flat mucosal lesions after neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Changlong Li;Zhen Guan;Yi Zhao;Tingting Sun;Zhongwu Li;Weihu Wang;Zhexuan Li;Lin Wang;Aiwen Wu-Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Gastrointestinal Cancer Center,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Radiology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Pathology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Radiation Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Cancer Epidemiology,Peking University Cancer Hospital&Institute,Beijing 100142,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。